V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009240 | 270005490 | 1.57 | 60.3 | Curative (C) | 2017-08-22 | 2017-08-22 | Escalated BEACOPP | 02 | N | 270017444 | BEACOPP |
| 270009241 | 270005490 | 1.8 | 92 | Disease modification (D) | 2016-12-20 | 2016-12-28 | CHOP R - 21 days | 2 | N | 270017444 | CHOP R |
| 270009242 | 270005490 | null | null | Curative (C) | 2015-04-28 | 2015-04-28 | VEPEMB | N | N | 270017444 | VEPEMB |
| 270009243 | 270005490 | null | null | Adjuvant (A) | 2015-07-10 | 2015-08-07 | Cisplatin 7 day | N | Y | 270017444 | CISPLATIN |
| 270009244 | 270005491 | null | 55.1 | null | 2018-02-14 | 2018-03-02 | Fluorouricil + Folonic Acid (MdG) | 2 | null | 270017452 | FLUOROURACIL |
| 270009245 | 270005491 | 1.83 | 80 | Curative (C) | 2013-06-30 | 2013-07-07 | Cisplatin | N | Y | 270017452 | CISPLATIN |
| 270009246 | 270005492 | null | null | Palliative (P) | 2014-03-16 | 2014-03-16 | CISPLATIN + FLUOROURACIL | null | N | 270017455 | CISPLATIN + FLUOROURACIL |
| 270009247 | 270005493 | 1.86 | 63.6 | Curative (C) | 2015-01-01 | 2015-01-08 | CHOP R | N | N | 270017456 | CHOP R |
| 270009248 | 270012733 | 1.79 | 60.3 | null | 2016-03-17 | 2016-04-11 | Trial Unspecified | N | Y | 270017457 | TRIAL |
| 270009249 | 270015980 | 1.46 | 60.8 | null | 2014-12-19 | 2014-12-22 | CHOP R - 21 days | 02 | N | 270017459 | CHOP R |
| 270009250 | 270015980 | 1.69 | 61 | Curative (C) | 2014-07-28 | 2014-07-28 | Cisplatin +Fluorouracil (2 wk) | 01 | N | 270017459 | CISPLATIN + FLUOROURACIL |
| 270009251 | 270018872 | 1.69 | 90 | Curative (C) | 2017-04-09 | 2017-04-12 | CHOP R | N | N | 270017462 | CHOP R |
| 270009252 | 270005494 | 1.64 | 105.6 | Neo-adjuvant (N) | 2015-09-18 | 2015-09-18 | HD EuroNet-PHL-C1 COPDAC | 02 | N | 270017463 | TRIAL |
| 270009253 | 270005495 | null | null | Curative (C) | 2017-07-31 | 2017-08-23 | Cisplatin | N | Y | 270017464 | CISPLATIN |
| 270009254 | 270005496 | 1.77 | 66.4 | null | 2016-06-08 | 2016-06-20 | CHOP R - 21 days | 02 | N | 270017465 | CHOP R |
| 270009255 | 270005497 | 1.77 | 79.45 | Curative (C) | 2017-09-09 | 2017-09-10 | CHOP R | Y | N | 270017466 | CHOP R |
| 270009256 | 270005498 | 1.75 | 69 | Neo-adjuvant (N) | null | 2014-11-19 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270017468 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270009257 | 270005498 | null | 85 | Curative (C) | 2014-05-08 | 2014-05-15 | Trial Unspecified | null | N | 270017468 | TRIAL |
| 270009258 | 270005499 | 1.7 | 74 | Curative (C) | 2015-10-30 | 2015-10-30 | Escalated BEACOPP | Y | N | 270017470 | BEACOPP |
| 270009259 | 270005500 | 1.68 | 84 | Curative (C) | 2016-03-29 | 2016-04-16 | Cisplatin | 01 | N | 270017471 | CISPLATIN |
| 270009260 | 270005500 | 1.47 | 96 | Curative (C) | null | 2017-01-02 | CISPLATIN + FLUOROURACIL | 2 | null | 270017471 | CISPLATIN + FLUOROURACIL |
| 270009261 | 270005501 | 1.81 | 87 | Curative (C) | 2017-04-25 | 2017-04-30 | CHOP R - 21 days | 2 | N | 270017474 | CHOP R |
| 270009262 | 270005502 | 1.59 | 80 | Disease modification (D) | 2015-03-12 | 2015-03-20 | VEPEMB | N | N | 270017475 | VEPEMB |
| 270009263 | 270005502 | 1.69 | 64 | Curative (C) | 2016-01-20 | 2016-01-31 | CISPLATIN + FLUOROURACIL | N | N | 270017475 | CISPLATIN + FLUOROURACIL |
| 270009264 | 270015981 | null | null | Curative (C) | 2015-07-29 | 2015-09-28 | Trial Unspecified | null | N | 270017479 | TRIAL |
| 270009265 | 270015981 | 1.84 | 60.2 | Curative (C) | 2013-07-30 | 2013-07-31 | CHOP R - 21 days | N | N | 270017479 | CHOP R |
| 270009266 | 270015981 | 1.74 | 90 | Curative (C) | 2016-09-20 | 2016-09-20 | CHOP R | 02 | N | 270017479 | CHOP R |
| 270009267 | 270005503 | 1.61 | 71 | Palliative (P) | 2017-03-25 | 2017-03-27 | CHOP R - 21 days | N | N | 270017485 | CHOP R |
| 270009268 | 270005504 | 1.7 | 69.3 | Neo-adjuvant (N) | 2014-06-03 | 2014-06-11 | CARBOPLATIN + RT | N | null | 270017486 | CARBOPLATIN |
| 270009269 | 270005505 | null | 91.5 | Adjuvant (A) | 2015-03-01 | 2015-03-21 | GDCVP | N | null | 270017488 | CVP R |
| 270009271 | 270005507 | 1.79 | 74 | Adjuvant (A) | 2015-09-08 | 2015-09-16 | Bevacizumab + Oxaliplatin +MdG | N | N | 270017492 | CETUXIMAB + IRINOTECAN + MDG |
| 270009272 | 270005508 | 1.81 | 78 | Palliative (P) | 2013-04-16 | 2013-04-21 | Bevacizumab + Oxaliplatin +MdG | N | Y | 270017493 | CETUXIMAB + IRINOTECAN + MDG |
| 270009273 | 270005508 | null | null | Curative (C) | 2016-01-26 | 2016-02-15 | CAP + RT | N | N | 270017493 | CETUXIMAB + RT |
| 270009274 | 270005508 | null | 111.75 | Palliative (P) | 2015-03-24 | 2015-04-25 | Bevacizumab + Cape + Oxali 21day | null | null | 270017493 | CARBO + FLUOROURACIL |
| 270009275 | 270005509 | 1.81 | null | Palliative (P) | 2013-04-22 | 2013-05-03 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270017497 | CARBOPLATIN + ETOPOSIDE |
| 270009276 | 270005510 | 1.68 | 96.7 | Palliative (P) | 2017-02-07 | 2017-02-07 | DHAP - R | 02 | N | 270017498 | NOT MATCHED |
| 270009277 | 270005511 | null | 78.75 | Palliative (P) | null | 2016-02-23 | Irinotecan | null | null | 270017499 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 270009278 | 270005511 | 1.41 | 91.5 | Curative (C) | 2016-08-29 | 2016-09-07 | Carboplatin + Etoposide iv&po | N | N | 270017499 | IRINOTECAN + MDG + PANITUMUMAB |
| 270009279 | 270005511 | 1.67 | 69 | Adjuvant (A) | 2014-12-27 | 2015-01-20 | CARBOPLATIN + RT | null | N | 270017499 | FLUOROURACIL + RT |
| 270009280 | 270005511 | 1.76 | null | Disease modification (D) | 2017-02-02 | 2017-03-07 | Hydroxycarbamide | N | Y | 270017499 | CHLORAMBUCIL |
| 270009281 | 270018874 | 1.75 | 58.4 | Curative (C) | 2017-07-30 | 2017-08-25 | GEMCARBO | N | N | 270017503 | CAPECITABINE + IRINOTECAN |
| 270009282 | 270005512 | null | 73 | Palliative (P) | 2013-04-30 | 2013-04-30 | Carboplatin + Irinotecan | N | N | 270017505 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 270009283 | 270005512 | 1.81 | 64.3 | Palliative (P) | 2016-08-26 | 2016-09-01 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 270017505 | GEMCARBO |
| 270009284 | 270005513 | 1.73 | 108.1 | Neo-adjuvant (N) | 2018-04-15 | 2018-05-05 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | N | N | 270017507 | TRIFLURIDINE + TIPIRACIL |
| 270009285 | 270005514 | 1.73 | 89.3 | Adjuvant (A) | 2016-06-22 | 2016-07-08 | TRASTUZUMAB | 2 | Y | 270017508 | CARBOPLATIN + RT |
| 270009286 | 270005515 | 1.6 | 95.5 | Curative (C) | null | 2017-02-11 | BENDAMUSTINE + RITUXIMAB | N | N | 270017509 | CISPLATIN + FLUOROURACIL + RT |
| 270009287 | 270005515 | 1.9 | 58.5 | Palliative (P) | null | 2015-06-07 | Carboplatin AUC 6 - 10 | N | N | 270017509 | CETUXIMAB |
| 270009288 | 270005516 | 1.7 | 88 | Curative (C) | 2018-01-26 | 2018-01-26 | Brentuximab | N | N | 270017516 | NHL 2003 |
| 270009289 | 270005517 | 1.65 | 61 | Palliative (P) | 2016-09-01 | 2016-09-03 | Carboplatin + Etoposide iv&po | Y | N | 270017520 | GEMCARBO |
| 270009290 | 270005518 | 1.73 | null | Curative (C) | 2013-11-06 | 2013-11-18 | SCOT TRIAL | N | N | 270017527 | CETUXIMAB + RT |